416 related articles for article (PubMed ID: 7702086)
21. Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia.
Grigelioniené G; Eklöf O; Laurencikas E; Ollars B; Hertel NT; Dumanski JP; Hagenäs L
Acta Paediatr; 2000 Sep; 89(9):1072-6. PubMed ID: 11071087
[TBL] [Abstract][Full Text] [Related]
22. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.
Su WC; Kitagawa M; Xue N; Xie B; Garofalo S; Cho J; Deng C; Horton WA; Fu XY
Nature; 1997 Mar; 386(6622):288-92. PubMed ID: 9069288
[TBL] [Abstract][Full Text] [Related]
23. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia.
Katsumata N; Mikami S; Nagashima-Miyokawa A; Nimura A; Sato N; Horikawa R; Tanae A; Tanaka T
Endocr J; 2000 Mar; 47 Suppl():S121-4. PubMed ID: 10890199
[TBL] [Abstract][Full Text] [Related]
25. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.
Muenke M; Schell U; Hehr A; Robin NH; Losken HW; Schinzel A; Pulleyn LJ; Rutland P; Reardon W; Malcolm S
Nat Genet; 1994 Nov; 8(3):269-74. PubMed ID: 7874169
[TBL] [Abstract][Full Text] [Related]
26. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
[TBL] [Abstract][Full Text] [Related]
27. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
[TBL] [Abstract][Full Text] [Related]
28. Achondroplasia-hypochondroplasia complex in a newborn infant.
Huggins MJ; Smith JR; Chun K; Ray PN; Shah JK; Whelan DT
Am J Med Genet; 1999 Jun; 84(5):396-400. PubMed ID: 10360392
[TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
Webster MK; Donoghue DJ
EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
[TBL] [Abstract][Full Text] [Related]
30. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
van Ravenswaaij-Arts CM; Losekoot M
Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
[TBL] [Abstract][Full Text] [Related]
31. An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.
Lanning RW; Brown CA
Hum Mutat; 1997; 10(6):496-9. PubMed ID: 9401015
[TBL] [Abstract][Full Text] [Related]
32. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
Superti-Furga A; Eich G; Bucher HU; Wisser J; Giedion A; Gitzelmann R; Steinmann B
Eur J Pediatr; 1995 Mar; 154(3):215-9. PubMed ID: 7758520
[TBL] [Abstract][Full Text] [Related]
33. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
Heuertz S; Le Merrer M; Zabel B; Wright M; Legeai-Mallet L; Cormier-Daire V; Gibbs L; Bonaventure J
Eur J Hum Genet; 2006 Dec; 14(12):1240-7. PubMed ID: 16912704
[TBL] [Abstract][Full Text] [Related]
34. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
Shiang R; Thompson LM; Zhu YZ; Church DM; Fielder TJ; Bocian M; Winokur ST; Wasmuth JJ
Cell; 1994 Jul; 78(2):335-42. PubMed ID: 7913883
[TBL] [Abstract][Full Text] [Related]
36. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
[TBL] [Abstract][Full Text] [Related]
37. Genotype phenotype correlation in achondroplasia and hypochondroplasia.
Matsui Y; Yasui N; Kimura T; Tsumaki N; Kawabata H; Ochi T
J Bone Joint Surg Br; 1998 Nov; 80(6):1052-6. PubMed ID: 9853502
[TBL] [Abstract][Full Text] [Related]
38. [Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].
Zhang Y; Yu W; Shen M; Fang Q; Fan M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):252-5. PubMed ID: 10932008
[TBL] [Abstract][Full Text] [Related]
39. PTH has the potential to rescue disturbed bone growth in achondroplasia.
Ueda K; Yamanaka Y; Harada D; Yamagami E; Tanaka H; Seino Y
Bone; 2007 Jul; 41(1):13-8. PubMed ID: 17466614
[TBL] [Abstract][Full Text] [Related]
40. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.
Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M
Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
